David E. Smolin, Ph.D., established DES Biologics Consulting, LLC in 2013 following a successful 36 year career in the pharmaceutical industry with a distinguished record of advancing multiple biologics from early discovery to registration and commercialization. DES Biologics Consulting provides complete technical consulting services as well as organizational development and program management to both small and large biologics companies for guiding pharmaceutical development, manufacturing and license approval by global health authorities. Dr. Smolin’s expertise in biologics extends to monoclonal antibodies, receptor-fusion proteins, antibody-drug conjugates and other recombinant proteins produced by both microbial fermentation and mammalian cell culture for many human health applications.
Prior to establishing DES Biologics Consulting, his most recent position was at the Bristol-Myers Squibb Company where he was Vice President, Biologics Process and Product Development. This role encompassed broad strategic and managerial responsibilities including establishment of the long-term business direction of the company for biologics , the assessment of in licensing opportunities, company acquisitions and their integration. He also had operational responsibility for over 300 scientists and engineers engaged in biologics process and product development. His notable accomplishments at Bristol-Myers Squibb include the US/EU and global registrations of Orencia® (abatacept) Nulojix® (belatacept) and Yervoy® (ipilimumab) and advancing several product candidates into mid and late stage clinical development. His technical leadership led to the subsequent approval of Opdivo® (nivolumab) for the treatment of several cancer types and Empliciti® (elotuzumab) for the treatment of multiple myeloma. He played a leading role to establish Bristol-Myers Squibb as a major developer of innovative biologics with one of the best pipelines in the industry.
His academic credentials include a B.S in Biology from the City College of New York as well as a M.S. and Ph.D. in Microbiology from Rutgers: The State University of New Jersey.
